Happy Holidays from Intrepid!
With the magic of the holiday season upon us, we donned our festive best to celebrate a transformative year for Intrepid. After eight thrilling years of growth, we joined MUFG,… Read more »
Banker Insights
Get Funded While the Getting Is Good
Despite all the geopolitical noise domestically and around the world, the stock market continues to soar to new highs and private equity and debt markets are following suit. If you or… Read more »
ACG OC SoCal Capital Summit
Join Us in Irvine for a Panel Discussion on Healthcare M&A Trends, Challenges, and Opportunities Intrepid’s Co-Head of Healthcare, Jonathan Bluth is speaking at the upcoming ACG SoCal Capital Summit…. Read more »
Intrepid Bolsters Its Consumer Products & Services Group with Hire of Industry Veteran Michael Garcia
Intrepid today announced that Michael Garcia has joined the firm as a Managing Director in the firm’s Consumer Products & Services Group. Mike will focus on disruptive and high-growth consumer… Read more »
Fit to Be Funded—Who’s Attracting Capital Right Now
Private debt and equity groups continue to raise new funds and compete aggressively to find deals. At the same time, concern about a potential turn in the market is leading… Read more »
Intrepid Advises Cicoil, LLC on Its Sale to TPC Wire & Cable Corp.
Intrepid announced today that it acted as the exclusive financial advisor to Cicoil, LLC (Cicoil) in connection with its acquisition by TPC Wire & Cable Corp. (TPC), a portfolio company… Read more »
Intrepid Launches Food, Beverage & Agriculture M&A Advisory; Michael Seccuro Joins to Lead the Practice
Intrepid announced today the launch of its Food, Beverage & Agriculture practice which will be led by industry veteran Michael Seccuro, Managing Director and Head of the Food, Beverage &… Read more »
Intrepid’s Half-Time Report
January 1, 2019, marked a new chapter in Intrepid’s evolution. We took a quantum leap in positioning our firm for profound growth. The changes were many—we added talent and capabilities… Read more »
Genetics Mega-Merger—The First Sample of More Consolidation?
In July 2019, Exact Sciences (NASDAQ: EXAS) announced it would acquire Genomic Health (NASDAQ: GHDX) for $2.8 billion in cash and stock. This was one of the largest M&A deals… Read more »